Matthew J Arango

2PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 17, 2022
First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population.

Alycia Hatashima, Matthew J Arango, Joshua Reardon

|Sep 09, 2019
Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience.

Justin C Tossey, Joshua Reardon, Jeffrey B VanDeusen

Pageof 1